← Leaderboards
Michael Litt
Vanderbilt University
$126,903
Attributed
$126,903
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2015–19$50K$37.5K$25K$12.5K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$126,903 · 1
By mechanism
F30$126,903 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Julien Albert Sebag$3,568,137
- Michael L. Freeman$14,431,534
- Sekhar Raja Konjeti$867,359
- James Andrew Hardaway$2,389,557
- Serena Sweet$94,680
Others in their field
Top investigators on “Cyclic Amp”
- Susan S Taylor · University Of California, San Diego$26,467,193
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Amy F.t. Arnsten · Yale University$18,857,746
- Andrew R Marks · Columbia University Health Sciences$17,939,974
- Jin Zhang · University Of California, San Diego$17,177,896
- Dennis Brown · Massachusetts General Hospital$16,250,225
Research focus
Cyclic AmpDoseCouplingAffinityAcquired Immunodeficiency SyndromeAdenylate CyclaseComparativeCongestive Heart FailureAnimal ModelAnimalsAgonistAppetite StimulantsArt ProteinBasal Metabolic RateAdvanced DiseaseAcuteAnalogBiological ModelsBody WeightCachexiaCell Culture TechniquesChronic Kidney FailureChronic Obstructive Airway DiseaseDrug Discovery
Grant awards (4)
Characterization of a new pharmacological approach to cachexia$8,466
F30 · FY2019 · DK · contact PI
Characterization of a new pharmacological approach to cachexia$49,524
F30 · FY2018 · DK · contact PI
Characterization of a new pharmacological approach to cachexia$41,433
F30 · FY2017 · DK · contact PI
Characterization of a new pharmacological approach to cachexia$27,480
F30 · FY2015 · DK · contact PI